Ghent University Academic Bibliography

Journal Article
A1
open access

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Sebastian M. Christ, Filippo Alongi, Umberto Ricardi, Marta Scorsetti, Lorenzo Livi, Panagiotis Balermpas, Yolande Lievens (UGent) , Pètra Braam, Barbara Alicja Jereczek-Fossa, Karin Stellamans, et al.

(2024) RADIOTHERAPY AND ONCOLOGY. 195.

Add to list

Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC : EORTC 22113-08113 LungTech phase II trial results

Antonin Levy, Sonja Adebahr, Coen Hurkmans, Merina Ahmed, Shahreen Ahmad, Matthias Guckenberger, Xavier Geets, Yolande Lievens (UGent) , Maarten Lambrecht, Nicolas Pourel, et al.

(2024) JOURNAL OF THORACIC ONCOLOGY. 19(9). p.1297-1309

Add to list

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

Stephanie G C Kroeze, Matea Pavic, Karin Stellamans, Yolande Lievens (UGent) , Carlotta Becherini, Marta Scorsetti, Filippo Alongi, Umberto Ricardi, Barbara Alicja Jereczek-Fossa, Paulien Westhoff, et al.

(2023) LANCET ONCOLOGY. 24(3). p.e121-e132

Add to list

ProCaLung : peer review in stage III, mediastinal node-positive, non-small-cell lung cancer : how to benchmark clinical practice of nodal target volume definition and delineation in Belgium

Florian Charlier, Thomas Descamps, Yolande Lievens (UGent) , Xavier Geets, Vincent Remouchamps, Maarten Lambrecht and Luigi Moretti

(2022) RADIOTHERAPY AND ONCOLOGY. 167. p.57-64

Add to list

Role of radiotherapy in the management of brain metastases of NSCLC : decision criteria in clinical routine

Markus Glatzer, Corinne Faivre-Finn, Dirk De Ruysscher, Joachim Widder, Paul Van Houtte, Esther G.C. Troost, Ben J. Slotman, Sara Ramella, Christoph Pöttgen, Stephanie T.H. Peeters, et al.

(2021) RADIOTHERAPY AND ONCOLOGY. 154. p.269-273

Add to list

Role of postoperative radiotherapy in the management for resected NSCLC : decision criteria in clinical routine pre- and post-LungART

Krisztian Süveg, Cecile Le Pechoux, Corinne Faivre-Finn, Paul M. Putora, Dirk De Ruysscher, Joachim Widder, Paul Van Houtte, Esther G.C. Troost, Ben J. Slotman, Sara Ramella, et al.

(2021) CLINICAL LUNG CANCER. 22(6). p.579-586

Add to list

ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer

Cecile Le Pechoux, Corinne Faivre-Finn, Sara Ramella, Fiona McDonald, Farkhad Manapov, Paul Martin Putora, Ben Slotman, Dirk De Ruysscher, Umberto Ricardi, Xavier Geets, et al.

(2020) RADIOTHERAPY AND ONCOLOGY. 152. p.89-95

Add to list

Journal Article
A1
open access

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR : a multicentre, randomised controlled open-label phase II trial

Relinde I. Y. Lieverse, Evert J. Van Limbergen, Cary J. G. Oberije, Esther G. C. Troost, Sine R. Hadrup, Anne-Marie C. Dingemans, Lizza E. L. Hendriks, Franziska Eckert, Crispin Hiley, Christophe Dooms, et al.

(2020) BMC CANCER. 20(1).

Add to list

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

Ursula Nestle, Dirk De Ruysscher, Umberto Ricardi, Xavier Geets, Jose Belderbos, Christoph Poettgen, Rafal Dziadiuszko, Stephanie Peeters, Yolande Lievens (UGent) , Coen Hurkmans, et al.

(2018) RADIOTHERAPY AND ONCOLOGY. 127(1). p.1-5

Academic Bibliography

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC : EORTC 22113-08113 LungTech phase II trial results

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

ProCaLung : peer review in stage III, mediastinal node-positive, non-small-cell lung cancer : how to benchmark clinical practice of nodal target volume definition and delineation in Belgium

Role of radiotherapy in the management of brain metastases of NSCLC : decision criteria in clinical routine

Role of postoperative radiotherapy in the management for resected NSCLC : decision criteria in clinical routine pre- and post-LungART

ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR : a multicentre, randomised controlled open-label phase II trial

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

Contents

Support

Contact